Cannara Biotech Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Cannara Biotech stock has a consensus rating of "Strong Buy" and an average price target of $3.19. The average 1-year stock price forecast is 96.91% higher than the current stock price, while the lowest is $3.00 (+85.19%) and the highest is $3.50 (+116.05%).

Price Target: $3.19 (+96.91%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$3.19	$3.13	$3.50
Change	+85.19%	+96.91%	+93.21%	+116.05%

* Price targets were last updated on May 7, 2026.

Analyst Ratings

The average analyst rating for Cannara Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	2	3	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	2	3	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Nicholas Cortellucci Atrium Research	Atrium Research	Buy Maintains $3.00	Buy	Maintains	$3.00	+85.19%	May 7, 2026
Derek Lessard TD Cowen	TD Cowen	Buy Maintains $3.25	Buy	Maintains	$3.25	+100.62%	Apr 16, 2026
Neal Gilmer Haywood	Haywood	Buy Initiates $3.00	Buy	Initiates	$3.00	+85.19%	Apr 7, 2026

Financial Forecast

Revenue This Year

122.76M

from 107.20M

14.51%

from 107.20M

Revenue Next Year

138.99M

from 122.76M

13.23%

from 122.76M

EPS This Year

0.12

from 0.14

-11.91%

from 0.14

EPS Next Year

0.19

from 0.12

51.36%

from 0.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Aug 31, 2021	Aug 31, 2022	Aug 31, 2023	Aug 31, 2024	Aug 31, 2025	Aug 31, 2026
Revenue	17.02M	35.84M	57.26M	81.75M	107.20M	122.76M
Revenue Growth	567.25%	110.58%	59.76%	42.77%	31.14%	14.51%
Gross Profit	10.30M	17.33M	27.23M	29.79M	47.10M	52.66M
Gross Margin	60.50%	48.36%	47.56%	36.44%	43.94%	42.90%
Operating Income	52.60K	4.82M	11.72M	7.64M	21.66M	21.88M
Net Income	-1.53M	2.31M	6.95M	6.44M	13.08M	12.92M
EPS	-	-	-	-	0.14	0.12
EPS Growth	-	-	-	-	-	-11.91%
Forward PE	-	-	-	-	-	13.14
Free Cash Flow	-33.71M	-23.81M	-11.46M	-7.43M	10.10M	12.75M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2026	2027	2028
High	127.3M
Avg	122.8M
Low	118.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	18.8%
Avg	14.5%
Low	10.1%

EPS Forecast

EPS	2026	2027	2028
High	0.16
Avg	0.12
Low	0.10

EPS Growth

EPS Growth	2026	2027	2028
High	14.3%
Avg	-11.9%
Low	-28.6%